Laon Medi Signs Strategic Partnership with Uclear, Accelerating Entry into the U.S. and Latin American Markets

FDA-Cleared Laon Ortho Launches Officially in the Americas

Laon Medi Announces Global Market Expansion at GNYDM 2025, Marking Full-Scale Entry into the U.S. Clear Aligner Market

Laon Medi will unveil its “Complete Digital Workflow for Clear Aligners”—an end-to-end platform integrating planning, review, and manufacturing—at GNYDM 2025, officially launching its FDA-cleared entry into the U.S. market.

Laon Medi Selected as a “Promising Small and Medium Enterprise of Gyeonggi Province”

Laon Medi has been officially certified as a Promising SME (Small and Medium Enterprise) by Gyeonggi Province.

Laon Medi to Showcase at the 58th Annual Congress of the Korean Association of Orthodontists

Presenting the Complete AI-Powered Digital Workflow for Clear Aligners

Laon Medi Signs Strategic Partnership with Graphy for Next-Generation Clear Aligner System

Laon Medi Inc. (CEO Seok-Joong Lee), the AI healthcare subsidiary of Laon People, has signed a memorandum of understanding (MOU) with Graphy Inc. (CEO Woon-Seop Shim), a leading company in dental materials, to jointly develop dental software and embark on full-scale collaboration.

Laon Ortho Showcased at KSDO Symposium as Key Driver for In-office Clear Aligner Treatments

At the latest symposium hosted by the Korean Society of Digital Orthodontics (KSDO), orthodontic specialists shared their clinical experiences using Laon Ortho for In-office clear aligner treatments.

Gold Award at the Clear Aligner Lab Contest with a Laon Ortho Digital Setup

Seonjoong Byun, Product Owner (PO) for Laon Ortho at Laon Medi, has won the Gold Award at the Clear Aligner Lab Contest hosted by Osstem Implant.

Laon Medi Meets Leading Korean and Japanese Orthodontic Experts at K-iDT

On September 7, 2025, Laon Medi took part in the Korean Integrated Dentistry Society (K-iDT) event.

Five Promising Bio & Healthcare Startups from Gyeonggi Province Join Boston Investment Readiness Program

Five promising bio and healthcare startups based in Gyeonggi Province will participate in an investment readiness program in Boston, USA. Genexis Co., Ltd., a bio-healthcare–focused accelerator, announced that it will operate the “Boston On-Site Program” from September 14 to 20.

Laon Medi Signs Software Development and Supply Agreement with DIO Implant

Laon Medi (CEO Seok-Joong Lee), the AI healthcare subsidiary of Laon People, announced on the 21st that it has signed an agreement with DIO Implant (CEO Jong-Won Kim), a global leader in digital implant solutions, for the joint development and supply of dental software. The signing ceremony took place at Laon Medi’s headquarters in Gwacheon, Korea.